臨床診斷市場：按測試、產品和最終用戶分類 - 2023-2030 年全球預測

全球臨床診斷市場預計到2023年將達到778億美元，年複合成長率為8.52%，預計到2030年將成長至驚人的1385.3億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球臨床診斷市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球臨床診斷試劑市場規模及預測如何？

2.在預測期內，COVID-19對全球臨床診斷市場的抑制要素和影響是什麼？

3. 在預測期內，全球臨床診斷市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球臨床診斷試劑市場的競爭策略是什麼？

5.全球臨床診斷市場的技術趨勢和法律規範是什麼？

6.全球臨床診斷市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球臨床診斷市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 感染疾病和慢性病發病率增加
    • 採用自動診斷平台
    • 基因檢測的需求不斷成長
  • 抑制因素
    • 設置和設備成本高
  • 機會
    • 臨床診斷設備新發展
    • 加大臨床研究投入
  • 任務
    • 熟練研究人員數量有限
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通貨膨脹的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 臨床診斷市場測試

• 電解質檢測臨床診斷劑
• 傳染病檢查臨床診斷劑
• 全血細胞計數臨床診斷劑
• 血脂檢測臨床診斷劑
• 肝病臨床診斷劑
• 腎臟面板臨床診斷劑

第7章 臨床診斷市場：副產品

• 樂器
• 試劑

第8章 臨床診斷市場：按最終用戶分類

• 診斷實驗室
• 醫院實驗室
• 即時檢測

第9章 美洲臨床診斷市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太臨床診斷市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲臨床診斷市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可和定價

The Global Clinical Diagnostics Market is forecasted to grow significantly, with a projected USD 77.80 billion in 2023 at a CAGR of 8.52% and expected to reach a staggering USD 138.53 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Clinical Diagnostics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Clinical Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Test, market is studied across Clinical Diagnostics for Electrolyte Testing, Clinical Diagnostics for Infectious Disease Testing, Complete Blood Count Clinical Diagnostics, Lipid Panel Clinical Diagnostics, Liver Panel Clinical Diagnostics, and Renal Panel Clinical Diagnostics. The Renal Panel Clinical Diagnostics is projected to witness significant market share during forecast period.

Based on Product, market is studied across Instruments and Reagents. The Instruments is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Diagnostic Laboratories, Hospital Laboratories, and Point-of-Care Testing. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Clinical Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Diagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Diagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Diagnostics Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Diagnostics Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Diagnostics Market?

6. What is the market share of the leading vendors in the Global Clinical Diagnostics Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Diagnostics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Clinical Diagnostics Market, by Test, 2022 vs 2030
• 4.3. Clinical Diagnostics Market, by Product, 2022 vs 2030
• 4.4. Clinical Diagnostics Market, by End-User, 2022 vs 2030
• 4.5. Clinical Diagnostics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of infectious and chronic diseases
    • 5.1.1.2. Adoption of automated diagnostic platforms
    • 5.1.1.3. Increasing need for genetic test
  • 5.1.2. Restraints
    • 5.1.2.1. High setup and instruments cost
  • 5.1.3. Opportunities
    • 5.1.3.1. New developments in clinical diagnostics equipments
    • 5.1.3.2. Increasing investment for clinical research
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled laboratory persons
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Clinical Diagnostics Market, by Test

• 6.1. Introduction
• 6.2. Clinical Diagnostics for Electrolyte Testing
• 6.3. Clinical Diagnostics for Infectious Disease Testing
• 6.4. Complete Blood Count Clinical Diagnostics
• 6.5. Lipid Panel Clinical Diagnostics
• 6.6. Liver Panel Clinical Diagnostics
• 6.7. Renal Panel Clinical Diagnostics

7. Clinical Diagnostics Market, by Product

• 7.1. Introduction
• 7.2. Instruments
• 7.3. Reagents

8. Clinical Diagnostics Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospital Laboratories
• 8.4. Point-of-Care Testing

9. Americas Clinical Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Clinical Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CLINICAL DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL DIAGNOSTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2022 VS 2030 (%)
• FIGURE 5. CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 6. CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. CLINICAL DIAGNOSTICS MARKET DYNAMICS
• FIGURE 9. CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CLINICAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 5. CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL DIAGNOSTICS FOR ELECTROLYTE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL DIAGNOSTICS FOR INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CLINICAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CLINICAL DIAGNOSTICS MARKET SIZE, BY LIVER PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CLINICAL DIAGNOSTICS MARKET SIZE, BY RENAL PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 12. CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 146. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 147. CLINICAL DIAGNOSTICS MARKET LICENSE & PRICING